Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy

NCT01500720 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01500720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of Cabazitaxel Versus Topotecan in Small Cell Lung Cancer Patients With Progressive Disease During or After a First Line Platinum Based Chemotherapy
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
April 30, 2014
Enrollment
179 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer